Source:http://linkedlifedata.com/resource/pubmed/id/11051263
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2001-1-29
|
pubmed:abstractText |
We have documented previously that adenovirus-mediated interleukin 12 (IL-12) gene therapy is effective for orthotopic tumor control and suppression of pre-established metastases in a preclinical prostate cancer model (Y. Nasu et al., Gene Ther., 6: 338-349, 1999). In this report, we directly compare the effectiveness of an adenovirus that expresses both IL-12 and the costimulatory molecule B7-1 (AdmIL12/B7) with one that expresses IL-12 alone (AdmIL-12) using the poorly immunogenic RM-9 orthotopic murine model of prostate cancer. We document AdmIL-12/B7-mediated secretion of IL-12 and increased surface expression of B7-1 in infected RM-9 tumor cells. A significant reduction in orthotopic tumor size and increased survival was demonstrated in mice treated with a single orthotopic injection of AdmIL-12/B7 compared with AdmIL-12 or controls. Six of 19 animals treated with AdmIL-12/B7 survived long term with apparent eradication of the primary tumor in contrast to one of 38 animals in the AdmIL-12-treated group. Orthotopic treatment of tumors with both vectors led to an infiltration of both CD4+ and CD8+ immunoreactive cells, with AdmIL-12/B7 treatment having a more prolonged infiltration of CD8+ cells. AdmIL-12/B7 was also more effective than AdmIL-12 or controls at suppression of pre-established metastases. We further developed a vaccine model based on s.c. injection of infected, irradiated RM-9 cells and found that both AdmIL-12 and AdmIL-12/B7 are effective at suppressing the development and growth of challenge orthotopic tumors using this protocol.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD4,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD8,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD80,
http://linkedlifedata.com/resource/pubmed/chemical/Cancer Vaccines,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-12
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1078-0432
|
pubmed:author |
pubmed-author:AlbanoDD,
pubmed-author:BangmaC HCH,
pubmed-author:EbaraSS,
pubmed-author:HullG WGW,
pubmed-author:LeeH MHM,
pubmed-author:MccurdyM AMA,
pubmed-author:NashDD,
pubmed-author:SatoTT,
pubmed-author:ShimuraSS,
pubmed-author:ThompsonT CTC,
pubmed-author:TimmeT LTL,
pubmed-author:WangJJ,
pubmed-author:YanoOO
|
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4101-9
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:11051263-Adenoviridae,
pubmed-meshheading:11051263-Animals,
pubmed-meshheading:11051263-Antigens, CD4,
pubmed-meshheading:11051263-Antigens, CD8,
pubmed-meshheading:11051263-Antigens, CD80,
pubmed-meshheading:11051263-Cancer Vaccines,
pubmed-meshheading:11051263-Flow Cytometry,
pubmed-meshheading:11051263-Gene Therapy,
pubmed-meshheading:11051263-Humans,
pubmed-meshheading:11051263-Immunohistochemistry,
pubmed-meshheading:11051263-Interleukin-12,
pubmed-meshheading:11051263-Kinetics,
pubmed-meshheading:11051263-Lung Neoplasms,
pubmed-meshheading:11051263-Male,
pubmed-meshheading:11051263-Mice,
pubmed-meshheading:11051263-Mice, Inbred C57BL,
pubmed-meshheading:11051263-Neoplasm Transplantation,
pubmed-meshheading:11051263-Prostatic Neoplasms,
pubmed-meshheading:11051263-Time Factors,
pubmed-meshheading:11051263-Tumor Cells, Cultured
|
pubmed:year |
2000
|
pubmed:articleTitle |
Prostate cancer gene therapy: comparison of adenovirus-mediated expression of interleukin 12 with interleukin 12 plus B7-1 for in situ gene therapy and gene-modified, cell-based vaccines.
|
pubmed:affiliation |
Scott Department of Urology Baylor College of Medicine, Houston, Texas 77030, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.
|